Pharma News

US biotech Acorda Therapeutics is discontinuing development of its experimental Parkinson’s disease therapy tozadenant on concerns over patient safety.

European regulators have cleared Tesaro’s Zejula, offering a new option for the maintenance treatment of certain adults with platinum-sensitive relapsed high grade serous epithelial ovarian, fallopi...

The U.

Pharma stands to win again in Washington, D.

RBC Capital Markets analyst Randall Stanicky sees lots of reasons Allergan should pursue a breakup.

The US Food and Drug Administration has granted Breakthrough Therapy designation (BTD) for patisiran, an investigational RNAi therapeutic targeting transthyretin (TTR) for the treatmen...

Japan’s biggest drugmaker is ready to take on more partnerships and deals -- at the right price -- as it seeks to build an identity beyond the pharmacy shelves of its home market.

CAPE TOWN (Reuters) - Developing new antiretroviral (ARV) drugs and using technology for early diagnosis are among steps needed to sustain momentum in fighting HIV/AIDS and ending the ...

Science Exchange announced a strategic partnership with Alector, a biotech company pioneering the discovery & development of immuno-neurology therapies for neurodegenerative disorders, to provide ...

PeptiDream has entered into a multi-target discovery collaboration with Germany-based Bayer AG.

Quotient Sciences has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.

A new online resource from CVS Health is showcasing the company’s impact on communities.